In a post by Jean-Charles Soria on Linkedin, it says, “The cancer treatment landscape has changed dramatically since 2000. This Review summarizes trends in the approval of oncology therapeutic products by fda from 2000 to 2022, based on a categorization of these products by their mechanism of action & primary target. A must read.”
For details: Click here
Source: Jean-Charles Soria/Linkedin
